EFFECT OF GLUCOSE, INSULIN, AND HYPERTONICITY ON ATRIAL-NATRIURETIC-PEPTIDE LEVELS IN MAN

被引:29
作者
CLARK, BA
SCLATER, A
EPSTEIN, FH
ELAHI, D
机构
[1] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT MED,DIV NEPHROL,BOSTON,MA 02215
[2] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT MED,DIV GERONTOL,BOSTON,MA 02215
[3] HARVARD UNIV,CTR STUDY KIDNEY DIS,CAMBRIDGE,MA 02138
[4] BROCKTON W ROXBURY VET ADM MED CTR,CTR GERIATR RES EDUC CLIN,BOSTON,MA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1993年 / 42卷 / 02期
关键词
D O I
10.1016/0026-0495(93)90040-U
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the effect of hyperglycemia and hyperinsulinemia on atrial natriuretic peptide (ANP) levels in man, we studied normotensive nondiabetic volunteers (aged 25 to 63 years) during infusion of insulin and/or 20% dextrose (glucose clamp technique) to achieve three different states of "glycemia/hyperinsulinemia," as follows: (1) euglycemia for 2 hours during infusion of insulin (80 mU · m-2 · min-1), resulting in plasma insulin levels of approximately 1,200 pmol/L (n = 9); (2) moderate stable hyperglycemia at a level of 11 mmol/L (198 mg/dL) for 2 hours, with infusion of glucagon-like peptide-1 (7-37) amide (GLP-1) during the second hour, which increased endogenous insulin responses to approximately 2,100 pmol/L (n = 9); and (3) marked stable hyperglycemia at a level of 18.5 mmol/L (330 mg/dL) for 2 hours, with endogenous insulin responses of approximately 720 pmol/L (n = 9). In addition, six patients with non-insulin-dependent diabetes mellitus were studied with the GLP-1 protocol at a hyperglycemic level of 14.5 mmol/L (261 mg/dL). In normal subjects, plasma ANP levels increased significantly from 3.0 ± 0.4 to 4.6 ± 0.8 pmol/L during marked hyperglycemia, but did not change during euglycemia or moderate hyperglycemia despite higher insulin levels (P < .01, ANOVA). Sodium excretion rates were also highest during the marked hyperglycemic study (125 ± 14 v 91 ± 7 v 74 ± 10 μmol/min, P < .05, marked v moderate hyperglycemia v euglycemia). In diabetic subjects, ANP levels increased significantly from 12.5 ± 4.1 to 21.1 ± 5.0 pmol/L during hyperglycemia. To determine the contribution of hypertonicity to the increases in ANP levels, seven subjects underwent infusion of 5% saline and 0.9% saline on separate occasions to produce equivalent degrees of volume expansion. Hypertonicity was shown to contribute significantly to ANP elevation, as the increment in ANP levels was significantly greater with 5% saline than with 0.9% saline despite similar changes in plasma volume. In summary, marked hyperglycemia produced acutely can increase plasma ANP levels via a mechanism that is unrelated to hyperinsulinemia; the mechanism may be related to an increase in both plasma tonicity and volume. Hyperglycemia may contribute to the increased circulating ANP levels observed in diabetic subjects. © 1993.
引用
收藏
页码:224 / 228
页数:5
相关论文
共 20 条
  • [1] BIOLOGICALLY-ACTIVE ATRIAL PEPTIDES
    BALLERMANN, BJ
    BRENNER, BM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (06) : 2041 - 2048
  • [2] FUNCTIONAL IMPLICATIONS OF DECREASED RENAL CORTICAL ATRIAL-NATRIURETIC-PEPTIDE BINDING IN EXPERIMENTAL DIABETES
    BENIGNI, A
    PERICO, N
    DADAN, J
    GABANELLI, M
    GALBUSERA, M
    BOCCARDO, P
    MENNINI, T
    REMUZZI, G
    [J]. CIRCULATION RESEARCH, 1990, 66 (06) : 1453 - 1460
  • [3] REGULATION OF SPLANCHNIC AND PERIPHERAL GLUCOSE-UPTAKE BY INSULIN AND HYPERGLYCEMIA IN MAN
    DEFRONZO, RA
    FERRANNINI, E
    HENDLER, R
    FELIG, P
    WAHREN, J
    [J]. DIABETES, 1983, 32 (01) : 35 - 45
  • [4] ESCAPE OF HEPATIC GLUCOSE-PRODUCTION DURING HYPERGLYCEMIC CLAMP
    ELAHI, D
    MENEILLY, GS
    MINAKER, KL
    ANDERSEN, DK
    ROWE, JW
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (05): : E704 - E711
  • [5] NONCALCIUM-DEPENDENT MODULATION OF INVITRO ATRIAL-NATRIURETIC-FACTOR RELEASE BY EXTRACELLULAR OSMOLALITY
    GIBBS, DM
    [J]. ENDOCRINOLOGY, 1987, 120 (01) : 194 - 197
  • [6] GOETZ K, 1986, AM J PHYSIOL, V254, pE1
  • [7] RELATIONSHIP BETWEEN ATRIAL GRANULARITY AND RELEASE OF ATRIAL NATRIURETIC FACTOR IN RATS WITH DIABETES-MELLITUS
    HEBDEN, RA
    TODD, ME
    MCNEILL, JH
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (04): : R932 - R938
  • [8] EFFECTS OF PLASMA-VOLUME AND OSMOLALITY ON SECRETION OF ATRIAL NATRIURETIC PEPTIDE AND VASOPRESSIN IN MAN
    KAMOI, K
    SATO, F
    ARAI, O
    ISHIBASHI, M
    YAMAJI, T
    [J]. ACTA ENDOCRINOLOGICA, 1988, 118 (01): : 51 - 58
  • [9] NAKAMURA T, 1990, JPN HEART J, V31, P671
  • [10] INSULINOTROPIC ACTION OF GLUCAGON-LIKE PEPTIDE-I-(7-37) IN DIABETIC AND NONDIABETIC SUBJECTS
    NATHAN, DM
    SCHREIBER, E
    FOGEL, H
    MOJSOV, S
    HABENER, JF
    [J]. DIABETES CARE, 1992, 15 (02) : 270 - 276